Literature DB >> 31299087

The clinical course of actinic keratosis correlates with underlying molecular mechanisms.

A Bakshi1,2, R Shafi1, J Nelson1, W C Cantrell1, S Subhadarshani1, A Andea3, M Athar1,4, C A Elmets1,4,5.   

Abstract

BACKGROUND: Actinic keratoses (AKs) are common premalignant skin lesions triggered by excessive ultraviolet exposure. The majority of AKs regress or persist, but some progress to squamous cell carcinomas. Biomarkers associated with their persistence, progression and regression have not been characterized.
OBJECTIVES: We performed skin biopsies in patients with extensive actinic damage to identify biomarkers that correlate with clinical progression and regression of AKs.
METHODS: This was an observational study of a cohort of patients with extensive actinic damage. AKs were mapped on a clear plastic template in 26 patients at months 3, 6, 9 and 11. Biopsies were taken from randomly selected, predetermined AKs and were evaluated for p53, E-cadherin, Snail, Slug and Twist. The study is registered at Clinicaltrials.gov: NCT00027976.
RESULTS: p53 exhibited greater expression in clinically apparent AKs (histological score 2·89 ± 1·45) than in regressed AKs (0·75 ± 0·96); P < 0·01. There was also significantly less membrane E-cadherin, the lack of which is a marker of epithelial-mesenchymal transition, in clinically apparent AKs (1·89 ± 1·81) than in sun-exposed skin (3·07 ± 1·75); P < 0·005. The E-cadherin transcription repressors Snail, Slug and Twist were increased in AKs compared with sun-exposed skin. A limitation of the study is that measurement of histological biomarkers was not a primary end point. In addition, patients were allowed to apply sunscreens.
CONCLUSIONS: At the molecular level, loss of E-cadherin and an increase in p53 are linked to the dynamic interplay between the persistence, progression and regression of AKs. What's already known about this topic? Actinic keratoses (AKs) are common dysplastic epidermal lesions that result from chronic and excessive ultraviolet exposure. Biomarkers associated with progression and regression of AK have not been characterized. What does this study add? Decreased E-cadherin and increased p53, Snail, Slug and Twist (E-cadherin transcription factors) were associated with progression from AK to nonmelanoma skin cancer. What is the translational message? Strategies targeting these molecules may be effective in reversing rising skin cancer rates. E-cadherin, p53, Snail, Slug and Twist are potential biomarkers that may be used to assess the efficacy of existing chemopreventive agents.
© 2019 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31299087      PMCID: PMC7309433          DOI: 10.1111/bjd.18338

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  37 in total

Review 1.  Actinic keratosis.

Authors:  Riccardo Rossi; Moira Mori; Torello Lotti
Journal:  Int J Dermatol       Date:  2007-09       Impact factor: 2.736

2.  Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults.

Authors:  J A Foote; R B Harris; A R Giuliano; D J Roe; T E Moon; B Cartmel; D S Alberts
Journal:  Int J Cancer       Date:  2001-01-20       Impact factor: 7.396

3.  Spontaneous remission of solar keratoses: the case for conservative management.

Authors:  R Marks; P Foley; G Goodman; B H Hage; T S Selwood
Journal:  Br J Dermatol       Date:  1986-12       Impact factor: 9.302

4.  Reduction of solar keratoses by regular sunscreen use.

Authors:  S C Thompson; D Jolley; R Marks
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

5.  High incidence and regression rates of solar keratoses in a queensland community.

Authors:  C Frost; G Williams; A Green
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

6.  High levels of p53 protein in UV-irradiated normal human skin.

Authors:  P A Hall; P H McKee; H D Menage; R Dover; D P Lane
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

7.  Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma.

Authors:  R P Gallagher; G B Hill; C D Bajdik; S Fincham; A J Coldman; D I McLean; W J Threlfall
Journal:  Arch Dermatol       Date:  1995-02

Review 8.  Pharmacoeconomic considerations in treating actinic keratosis.

Authors:  Marjorie V Neidecker; Mary Lynn Davis-Ajami; Rajesh Balkrishnan; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.

Authors:  Agustí Toll; Emili Masferrer; M E Hernández-Ruiz; Carla Ferrandiz-Pulido; Mireia Yébenes; Ane Jaka; Anna Tuneu; Anna Jucglà; Javier Gimeno; Teresa Baró; Beatriz Casado; Alberto Gandarillas; Irmgard Costa; Sergi Mojal; Raul Peña; Antonio García de Herreros; Vicenç García-Patos; Ramon M Pujol; Inmaculada Hernández-Muñoz
Journal:  J Dermatol Sci       Date:  2013-07-15       Impact factor: 4.563

10.  Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors.

Authors:  Anna Lyakhovitsky; Aviv Barzilai; Mina Fogel; Henri Trau; Monika Huszar
Journal:  Am J Dermatopathol       Date:  2004-10       Impact factor: 1.533

View more
  5 in total

Review 1.  A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).

Authors:  Benjamin Genenger; Jay R Perry; Bruce Ashford; Marie Ranson
Journal:  Discov Oncol       Date:  2022-06-06

2.  P53 staining index and zonal staining patterns in actinic keratoses.

Authors:  Sanja Javor; Giulia Gasparini; Valerio Gaetano Vellone; Aurora Parodi; Chiara Maria Biatta; Emanuele Cozzani; Francesco Cabiddu; Jean Louis Ravetti
Journal:  Arch Dermatol Res       Date:  2020-07-08       Impact factor: 3.017

3.  Protective effects of sunscreen (50+) and octatrienoic acid 0.1% in actinic keratosis and UV damages.

Authors:  Daniela Pinto; Anna Trink; Giammaria Giuliani; Fabio Rinaldi
Journal:  J Investig Med       Date:  2021-09-16       Impact factor: 2.895

Review 4.  Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.

Authors:  Stephenie Droll; Xiaomin Bao
Journal:  Cell Physiol Biochem       Date:  2021-09-22

5.  TP53 Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours.

Authors:  Raquel Martín-Sanz; José María Sayagués; Pilar García-Cano; Mikel Azcue-Mayorga; María Del Carmen Parra-Pérez; María Ángeles Pacios-Pacios; Enric Piqué-Durán; Jorge Feito
Journal:  Dermatopathology (Basel)       Date:  2021-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.